Island Company Lifestyle Products, LLC - rezultati iskanja

Združene države Amerike - angleščina - NLM (National Library of Medicine)

islander spf6- octinoxate, octisalate, avobenzone, octocrylene lotion

island company lifestyle products, llc - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm) - octinoxate 50 mg in 1 g - octinoxate 5.0% sunscreen octisalate 3.0% sunscreen oxybenzone 2.0% sunscreen avobenzone 2.0% sunscreen octocrylene 1.5% sunscreen - helps prevent sunburn - higher spf gives more sunburn protection - rash or irritation develops and lasts

Združene države Amerike - angleščina - NLM (National Library of Medicine)

traveler spf15- octinoxate, octisalate, oxybenzone, avobenzone, octocrylene lotion

Združene države Amerike - angleščina - NLM (National Library of Medicine)

tourist spf30- octinoxate, octisalate, oxybenzone, avobenzone, octocrylene lotion

island company lifestyle products, llc - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm) - octinoxate 75 mg in 1 g - octinoxate 7.5% sunscreen octisalate 5.0% sunscreen oxybenzone 5.0% sunscreen avobenzone 2.0% sunscreen octocrylene 1.5% sunscreen - helps prevent sunburn - higher spf gives more sunburn protection - rash or irritation develops and lasts

Evropska unija - angleščina - EMA (European Medicines Agency)

cellcept

roche registration gmbh - mycophenolate mofetil - graft rejection - immunosuppressants - cellcept is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.